1. Ismail WI, Hassali MA, Farooqui M, Saleem F. Complementary and alternative medicine use in patients with thalassemia in Malaysia. Arch. Pharma. Pract. 2018;9(1):7-13.
2. Galanello, R., Origa, R. Beta-thalassemia. Orphanet Journal of Rare Diseases, 2010, 5(11).
3. Viprakasit, V., Origa, R., Fucharoen, S. Guidelines for the management of transfusion dependent thalassemia (3rd ed.). Nicosia: Thalassemia International Federation. 2014.
4. Ng SY, Chan HK. A clinical pharmacistbased screening for depression in children with transfusiondependent thalassemia in Malaysia. Arch. Pharma. Pract. 2018;9(1):3-6.
5. Sadeghi M, Soltani M, Etemad K, Abdollahi M, Sayyadi M, Barzegar M, Salehnasab C, Rahmatinejad Z, Rezaei M, Valadbeigi T, Hajipour M. The prevalence of anti HCV infection and its related factors in patients with Beta-Thalassemia in Shiraz-Iran. Pharmacophores. 2018;9(1):80-84.